| Helvepharm AG - Rivastigmin Zentiva Patch 13.3 mg/24 h, transdermales Pflaster |
| 62917 | | 03 | | Rivastigmin Zentiva Patch 13.3 mg/24 h | | transdermales Pflaster | | N06DA03 | | Rivastigmine | | 11.02.2021 | | |
|
| Composition |
| rivastigminum 19.2 mg, excipiens ad praeparationem pro 12.8 cm² cum liberatione 13.3 mg/24h. |
| Packungsbestandteile |
| Transdermal patch | | | | | | | | Active Agent | Dose |
|---|
| Rivastigmine | 19.2 mg |
| | BAG: Active Agent | Dose |
|---|
| Rivastigmine | 19.2 mg |
|
|
|